These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26318673)

  • 1. Histone deacetylase inhibitors relieve morphine resistance in neuropathic pain after peripheral nerve injury.
    Uchida H; Matsushita Y; Araki K; Mukae T; Ueda H
    J Pharmacol Sci; 2015 Aug; 128(4):208-11. PubMed ID: 26318673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve Injury Diminishes Opioid Analgesia through Lysine Methyltransferase-mediated Transcriptional Repression of μ-Opioid Receptors in Primary Sensory Neurons.
    Zhang Y; Chen SR; Laumet G; Chen H; Pan HL
    J Biol Chem; 2016 Apr; 291(16):8475-85. PubMed ID: 26917724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDAC inhibitors restore C-fibre sensitivity in experimental neuropathic pain model.
    Matsushita Y; Araki K; Omotuyi Oi; Mukae T; Ueda H
    Br J Pharmacol; 2013 Nov; 170(5):991-8. PubMed ID: 24032674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain.
    Uchida H; Ma L; Ueda H
    J Neurosci; 2010 Mar; 30(13):4806-14. PubMed ID: 20357131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain.
    Rashid MH; Inoue M; Toda K; Ueda H
    J Pharmacol Exp Ther; 2004 Apr; 309(1):380-7. PubMed ID: 14718584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-restrictive silencer factor-mediated downregulation of μ-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain.
    Zhu C; Tang J; Ding T; Chen L; Wang W; Mei XP; He XT; Wang W; Zhang LD; Dong YL; Luo ZJ
    Pain; 2017 May; 158(5):879-890. PubMed ID: 28415063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitor-induced emergence of synaptic δ-opioid receptors and behavioral antinociception in persistent neuropathic pain.
    Tao W; Zhou W; Wang Y; Sun T; Wang H; Zhang Z; Jin Y
    Neuroscience; 2016 Dec; 339():54-63. PubMed ID: 27646288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suberoylanilide hydroxamic acid prevents downregulation of spinal glutamate transporter-1 and attenuates spinal nerve ligation-induced neuropathic pain behavior.
    Cui SS; Lu R; Zhang H; Wang W; Ke JJ
    Neuroreport; 2016 Apr; 27(6):427-34. PubMed ID: 26953753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reorganization of dorsal root ganglion neurons following chronic sciatic nerve constriction injury: correlation with morphine and lidocaine analgesia.
    Kolesnikov Y; El-Maarouf A; Rutishauser U; Pasternak G
    Eur J Pharmacol; 2007 Jul; 568(1-3):124-33. PubMed ID: 17543299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral effects of morphine and expression of μ-opioid receptors in the dorsal root ganglia during neuropathic pain: nitric oxide signaling.
    Hervera A; Negrete R; Leánez S; Martín-Campos JM; Pol O
    Mol Pain; 2011 Apr; 7():25. PubMed ID: 21486477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Berrocoso E; Garzón J
    Eur J Pharmacol; 2013 Sep; 716(1-3):94-105. PubMed ID: 23499699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring μ-opioid receptor in spinal cord.
    Hou X; Weng Y; Ouyang B; Ding Z; Song Z; Zou W; Huang C; Guo Q
    Brain Res; 2017 Aug; 1669():97-105. PubMed ID: 28559159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The etiological changes of acetylation in peripheral nerve injury-induced neuropathic hypersensitivity.
    Wang X; Shen X; Xu Y; Xu S; Xia F; Zhu B; Liu Y; Wang W; Wu H; Wang F
    Mol Pain; 2018; 14():1744806918798408. PubMed ID: 30105933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β and opioid receptor signaling crosstalk results in improvement of endogenous and exogenous opioid analgesia under pathological pain conditions.
    Lantero A; Tramullas M; Pílar-Cuellar F; Valdizán E; Santillán R; Roques BP; Hurlé MA
    J Neurosci; 2014 Apr; 34(15):5385-95. PubMed ID: 24719115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibition inhibits brachial plexus avulsion-induced neuropathic pain.
    Zhao Y; Wu T
    Muscle Nerve; 2018 Sep; 58(3):434-440. PubMed ID: 29742796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
    Wang D; Chen T; Zhou X; Couture R; Hong Y
    Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice.
    Jing L; Luo J; Zhang M; Qin WJ; Li YL; Liu Q; Wang YT; Lawrence AJ; Liang JH
    Neurosci Lett; 2011 Apr; 494(2):169-73. PubMed ID: 21396430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased methylation of the MOR gene proximal promoter in primary sensory neurons plays a crucial role in the decreased analgesic effect of opioids in neuropathic pain.
    Zhou XL; Yu LN; Wang Y; Tang LH; Peng YN; Cao JL; Yan M
    Mol Pain; 2014 Aug; 10():51. PubMed ID: 25118039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury.
    Uchida H; Sasaki K; Ma L; Ueda H
    Neuroscience; 2010 Mar; 166(1):1-4. PubMed ID: 20006971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC and HAT inhibitors differently affect analgesia mediated by group II metabotropic glutamate receptors.
    Zammataro M; Sortino MA; Parenti C; Gereau RW; Chiechio S
    Mol Pain; 2014 Nov; 10():68. PubMed ID: 25406541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.